Scarica l'app Stockscreener
8.25
0.09%
-0.02
Precedente Chiudi:
$8.27
Aprire:
$8.3
Volume 24 ore:
228.05K
Relative Volume:
0.25
Capitalizzazione di mercato:
$693.20M
Reddito:
$133.62M
Utile/perdita netta:
$-177.37M
Rapporto P/E:
-2.8547
EPS:
-2.89
Flusso di cassa netto:
$23.50M
1 W Prestazione:
-1.17%
1M Prestazione:
+9.15%
6M Prestazione:
-65.98%
1 anno Prestazione:
-57.30%
Intervallo 1D:
$7.88
$8.30
Intervallo di 1 settimana:
$7.88
$8.73
Portata 52W:
$7.16
$27.24
Xencor Inc Stock (XNCR) Company Profile
Nome
Xencor Inc
Settore
Industria
Telefono
626-305-5900
Indirizzo
465 N. HALSTEAD ST., PASADENA, CA
Confronta XNCR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
8.26 | 693.20M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.09 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
519.88 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.84 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
562.25 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
267.58 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | William Blair | Outperform |
| 2024-12-12 | Iniziato | Wells Fargo | Overweight |
| 2024-12-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | Reiterato | BTIG Research | Buy |
| 2024-02-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | Iniziato | BofA Securities | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-10-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | Iniziato | JP Morgan | Overweight |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-02-11 | Iniziato | BMO Capital Markets | Outperform |
| 2022-01-21 | Iniziato | SMBC Nikko | Outperform |
| 2021-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-02-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | Iniziato | Barclays | Underweight |
| 2020-02-25 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-01-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-11-20 | Ripresa | Guggenheim | Neutral |
| 2019-08-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | Iniziato | Mizuho | Buy |
| 2019-04-12 | Iniziato | Guggenheim | Buy |
| 2019-03-27 | Iniziato | Berenberg | Buy |
| 2019-03-15 | Iniziato | Raymond James | Outperform |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-03-28 | Ripresa | Leerink Partners | Outperform |
| 2017-03-02 | Iniziato | Instinet | Neutral |
| 2017-03-02 | Reiterato | Wedbush | Outperform |
| 2016-10-04 | Iniziato | Piper Jaffray | Overweight |
| 2015-12-22 | Iniziato | Canaccord Genuity | Buy |
| 2015-08-05 | Reiterato | MLV & Co | Buy |
| 2015-02-12 | Reiterato | Oppenheimer | Outperform |
| 2015-01-28 | Reiterato | MLV & Co | Buy |
| 2014-07-11 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Xencor Inc Borsa (XNCR) Ultime notizie
Closing Figures Unveiled: Xencor Inc (XNCR) Drop -8.18, Closes at 8.31 - DWinneX
Rhumbline Advisers Has $1.74 Million Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor (NASDAQ:XNCR) Shares Down 5.7% on Insider Selling - Defense World
(XNCR) On The My Stocks Page - news.stocktradersdaily.com
Xencor director Montgomery sells shares worth $20,422 - Investing.com
Xencor director Gustafson sells shares worth $27,595 - Investing.com
Xencor Holds Annual Stockholders Meeting on June 12 - TipRanks
Xencor (NASDAQ:XNCR) Trading Up 6.3%Should You Buy? - MarketBeat
USPTO Tells Fed. Circ. Not To Review Ruling In Xencor Case - Law360
Xencor, Inc. (NASDAQ:XNCR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Shares Purchased by California State Teachers Retirement System - Defense World
Bank of America Corp DE Sells 585,930 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
27,491 Shares in Xencor, Inc. (NASDAQ:XNCR) Acquired by Wellington Management Group LLP - Defense World
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Squarepoint Ops LLC - Defense World
When (XNCR) Moves Investors should Listen - news.stocktradersdaily.com
Xencor Inc (NASDAQ: XNCR) Jumps 2.45%: What Could Be On The Way Going Forward? - Stocksregister
Xencor, Inc. (XNCR) Stock Analysis: Exploring a Biotechnology Innovator with 264.58% Potential Upside - DirectorsTalk Interviews
Xencor’s SWOT analysis: biotech stock faces pivotal year amid pipeline progress - Investing.com Nigeria
Xencor’s SWOT analysis: biotech stock faces pivotal year amid pipeline progress By Investing.com - Investing.com South Africa
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $929,000 Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Where are the Opportunities in (XNCR) - news.stocktradersdaily.com
BNP Paribas Financial Markets Purchases 3,171 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Holdings Lowered by Jane Street Group LLC - Defense World
Deutsche Bank AG Buys 20,128 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (XNCR) Stock Analysis: Exploring a Potential 266% Upside in Biotech Investments - DirectorsTalk Interviews
Ameriprise Financial Inc. Has $6.72 Million Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Life Sciences Companies Have New Avenue to Challenge Patent Applications After Federal Court Ruling - JD Supra
Xencor, Inc. (NASDAQ:XNCR) Position Boosted by Comerica Bank - Defense World
Xencor Inc. Reports Revenue Growth Amidst Ongoing R&D Investments - TipRanks
Northern Trust Corp Increases Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Investor Network: Xencor, Inc. to Host Earnings Call - ACCESS Newswire
Xencor, Inc. (NASDAQ:XNCR) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Cancer Centers Want Fed. Circ. To Rehear Antibody IP Fight - Law360
Leerink Partnrs Has Bearish Forecast for Xencor Q2 Earnings - Defense World
Wedbush Comments on Xencor’s Q2 Earnings (NASDAQ:XNCR) - Defense World
Research Analysts Set Expectations for Xencor Q2 Earnings - Defense World
JPMorgan cuts Xencor stock price target to $20, keeps overweight rating - Investing.com Nigeria
Q4 Earnings Forecast for Xencor Issued By William Blair - Defense World
What is Wedbush’s Estimate for Xencor Q4 Earnings? - Defense World
Barclays Issues Pessimistic Forecast for Xencor (NASDAQ:XNCR) Stock Price - Defense World
Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Xencor (XNCR) and LivaNova (LIVN) - The Globe and Mail
Xencor Inc earnings missed by $0.04, revenue topped estimates - Investing.com Nigeria
Xencor (XNCR) Analyst Rating Update: Price Target Slashed by Bar - GuruFocus
Xencor (XNCR) Analyst Rating Update: Price Target Slashed by Barclays | XNCR Stock News - GuruFocus
JPMorgan cuts Xencor stock price target to $20, keeps overweight rating By Investing.com - Investing.com South Africa
Xencor Reports First Quarter 2025 Financial Results - BioSpace
Xencor: Q1 Earnings Snapshot - MySA
Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Xencor Inc Azioni (XNCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Xencor Inc Azioni (XNCR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GUSTAFSON KURT A | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
20,183 |
| GORMAN KEVIN CHARLES | Director |
Jun 16 '25 |
Sale |
9.22 |
3,173 |
29,255 |
18,905 |
| Feigal Ellen | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
19,183 |
| RANIERI RICHARD J | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
19,183 |
1.77%
0.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):